Office Dispensing Solutions
Keep More of Your 340B Savings
Stop Losing 30-40% of Your 340B Savings to Fees
RxFusion Office Dispensing helps smaller covered entities maximize 340B savings without the high costs of contract pharmacy. With just a 12% service fee, you retain significantly more revenue while gaining complete program control.
Contact: hello@rxfusion.com | www.rxfusion.com
❌ Contract Pharmacy Model
- TPA Fees:10-15%
- Contract Rx Fees:15-25%
- • True-Ups & Orphaned Accums
- • Rebate Drug Carve-Outs (1/1/26)
- • Manufacturer Restrictions
- • Complex Compliance
- Total Fees:30-40%
✓ RxFusion Office Dispensing
- All-Inclusive Fee:12%
- • No Contract Pharmacy Fees
- • No True-Ups or Orphans
- • All Drugs Included
- • Simple Rebate Compliance
- • Works with Existing Systems
- You Retain:88%
💡 Medicare Transaction Facilitator Compliance
RxFusion Office Dispensing simplifies Medicare Transaction Facilitator claim-level data requirements for covered entities. Eliminate lost value when contract pharmacies exclude drugs subject to these reporting requirements.
Real Savings: $500,000 340B Program
Contract Pharmacy
$500K Revenue - $175K Fees (35%) = $325K Gross
$325K Gross - $175K COGS (35%) = $150K Net
RxFusion Office Dispensing
$500K Revenue - $60K Fee (12%) = $440K Gross
$440K Gross - $175K COGS (35%) = $265K Net
Additional $115,000 Annual Savings (77% More Net Profit)
Ready to maximize your 340B savings?
Contact: hello@rxfusion.com | www.rxfusion.com
Real-World Drug Comparison
See how RxFusion Office Dispensing compares to contract pharmacy on high-cost brand and specialty medications
❌ Contract Pharmacy Model (Per Prescription)
| Drug | Revenue | Fees | 340B Cost | Net (High) | Net (Low) |
|---|
| Ozempic | $950 | $200-$400 | $320 | $430 | $230 |
| Biktarvy | $4,200 | $800-$1,700 | $2,829 | $571 | $0 |
| Eliquis | $600 | $120-$250 | $10 | $470 | $340 |
✓ RxFusion Office Dispense (Per Prescription)
| Drug | Revenue | RxFusion (12%) | 340B Cost | Net Profit | Improvement |
|---|
| Ozempic | $950 | $119 | $320 | $511 | Up to 122% |
| Biktarvy | $4,200 | $525 | $2,829 | $846 | Up to 350% |
| Eliquis | $600 | $75 | $10 | $515 | Up to 51% |
Impact of IRA and 340B Rebate Pilot
| Drug | Date | Revenue Impact | 340B Price | Contract Rx Impact |
|---|
| Ozempic | 2027 | Expected <$300 | Will Rise | May Not Qualify |
| Biktarvy | Unknown | - | Unaffected | Included |
| Eliquis | 2026 | <$300 under IRA | Will Rise | Dropped by many CPs |
Comprehensive Service Package
Far beyond basic TPA and contract pharmacy service levels
🚀Implementation
Complete setup, training & onboarding
🤝PBM Contracting
Negotiate & manage payor relationships
📋Policy & Compliance
340B policy development & audit support
💰Claims Management
Billing & reconciliation services
💻Software Platform
Integrated dispensing & compliance tools
📦Drug Purchasing
340B procurement & inventory management
💊Patient Support
Financial assistance program coordination
🔄Ongoing Support
Continuous compliance & operational guidance
✅Easy Implementation
Keep your wholesaler, EHR & TPA. No TPA required!
📊 Annual Program Projection (10 drugs/day, 5 days/week)
| Model | Volume | Fees | Gross | COGS (35%) | Net Profit | Advantage |
|---|
| Contract Pharmacy | $5M | $1.75M (35%) | $3.25M | $1.75M | $1.5M | - |
| RxFusion Office Dispense | $5M | $600K (12%) | $4.4M | $1.75M | $2.65M | +$1.15M (77%) |
Based on 2,600 prescriptions annually (10/day × 5 days × 52 weeks) with average Rx value of ~$1,920
Ready to maximize your 340B savings?
Partner with RxFusion to retain more of your 340B value while providing better patient care.
Contact: hello@rxfusion.com | www.rxfusion.com
